10 Best High Quality Low Peg Stocks for November 2025
Welcome to the Value Sense Blog, your resource for insights on the stock market! At Value Sense, we focus on intrinsic value tools and offer stock ideas with undervalued companies. Dive into our research products and learn more about our unique approach at valuesense.io
Explore diverse stock ideas covering technology, healthcare, and commodities sectors. Our insights are crafted to help investors spot opportunities in undervalued growth stocks, enhancing potential returns. Visit us to see evaluations and in-depth market research.
Market Overview & Selection Criteria
The 2025 equity landscape is defined by rapid technological innovation, resilient healthcare demand, and a renewed focus on capital efficiency. Our stock picks leverage ValueSense’s proprietary intrinsic value models, blending discounted cash flow and peer-relative analysis to identify companies with strong fundamentals, robust free cash flow, and attractive growth profiles[1][2]. Each selection is filtered for sector leadership, quality ratings, and risk-adjusted return potential, ensuring a diversified, high-conviction watchlist.
Featured Stock Analysis
Stock #1: Broadcom Inc. (AVGO)
| Metric | Value |
|---|---|
| Market Cap | $1,742.4B |
| Quality Rating | 8.2 |
| Intrinsic Value | $104.8 |
| 1Y Return | 117.7% |
| Revenue | $59.9B |
| Free Cash Flow | $24.9B |
| Revenue Growth | 28.0% |
| FCF margin | 41.6% |
| Gross margin | 66.8% |
| ROIC | 15.1% |
| Total Debt to Equity | 87.7% |
Investment Thesis
Broadcom Inc. stands out as a semiconductor and infrastructure software leader, boasting a massive $1.74 trillion market cap. The company’s robust revenue of $59.9B and free cash flow of $24.9B underscore its operational strength. With a ValueSense quality rating of 8.2 and an intrinsic value of $104.8, Broadcom’s fundamentals are supported by a 28% revenue growth rate and a 41.6% FCF margin. Its 1-year return of 117.7% highlights strong market momentum, while a gross margin of 66.8% and ROIC of 15.1% reflect efficient capital deployment.
Key Catalysts
- Expansion in AI and cloud infrastructure markets
- Strategic acquisitions bolstering software and hardware integration
- Consistent free cash flow generation supporting shareholder returns
Risk Factors
- High debt-to-equity ratio 87.7% could limit financial flexibility
- Cyclical demand in semiconductors may impact near-term growth
- Competitive pressures from both established and emerging tech players
Stock #2: Taiwan Semiconductor Manufacturing Company Limited (TSM)
| Metric | Value |
|---|---|
| Market Cap | $1,558.3B |
| Quality Rating | 8.2 |
| Intrinsic Value | $415.7 |
| 1Y Return | 58.1% |
| Revenue | NT$3,631.4B |
| Free Cash Flow | NT$889.9B |
| Revenue Growth | 37.0% |
| FCF margin | 24.5% |
| Gross margin | 59.0% |
| ROIC | 36.2% |
| Total Debt to Equity | 19.0% |
Investment Thesis
TSMC is the world’s largest dedicated semiconductor foundry, with a $1.56 trillion market cap and a ValueSense quality rating of 8.2. Its revenue of NT$3,631.4B and free cash flow of NT$889.9B are driven by a 37% revenue growth rate and a 24.5% FCF margin. The company’s 1-year return of 58.1% and an impressive ROIC of 36.2% reflect its dominance in advanced chip manufacturing. TSMC’s intrinsic value is calculated at $415.7, indicating potential upside relative to current market valuations.
Key Catalysts
- Leadership in advanced process nodes (3nm, 5nm) for AI and high-performance computing
- Strategic partnerships with global tech giants
- Strong balance sheet with low debt-to-equity 19.0%
Risk Factors
- Geopolitical tensions in the Taiwan Strait
- Customer concentration risk (notably Apple and Nvidia)
- Capital intensity of ongoing technology upgrades
Stock #3: Eli Lilly and Company (LLY)
| Metric | Value |
|---|---|
| Market Cap | $774.8B |
| Quality Rating | 7.7 |
| Intrinsic Value | $245.7 |
| 1Y Return | 4.3% |
| Revenue | $59.4B |
| Free Cash Flow | $9,020.7M |
| Revenue Growth | 45.4% |
| FCF margin | 15.2% |
| Gross margin | 83.0% |
| ROIC | 36.0% |
| Total Debt to Equity | 178.2% |
Investment Thesis
Eli Lilly is a pharmaceutical powerhouse with a $774.8B market cap and a ValueSense quality rating of 7.7. The company’s $59.4B in revenue and $9B in free cash flow are supported by a remarkable 45.4% revenue growth rate and an 83% gross margin. Despite a modest 1-year return of 4.3%, Lilly’s intrinsic value of $245.7 and ROIC of 36% highlight its profitability and innovation pipeline, particularly in diabetes and obesity treatments.
Key Catalysts
- Blockbuster drug launches in metabolic and oncology segments
- Expanding global footprint in emerging markets
- Industry-leading gross margin 83.0%
Risk Factors
- High debt-to-equity ratio 178.2% increases financial leverage risk
- Patent cliffs and regulatory scrutiny on drug pricing
- Competitive threats from biosimilars
Stock #4: Johnson & Johnson (JNJ)
| Metric | Value |
|---|---|
| Market Cap | $458.7B |
| Quality Rating | 6.3 |
| Intrinsic Value | $186.0 |
| 1Y Return | 20.0% |
| Revenue | $92.1B |
| Free Cash Flow | $19.1B |
| Revenue Growth | 5.1% |
| FCF margin | 20.7% |
| Gross margin | 68.1% |
| ROIC | 11.2% |
| Total Debt to Equity | 8.1% |
Investment Thesis
Johnson & Johnson, with a $458.7B market cap and a ValueSense quality rating of 6.3, is a diversified healthcare conglomerate. Its $92.1B in revenue and $19.1B in free cash flow are anchored by a 5.1% revenue growth rate and a 68.1% gross margin. The company’s 1-year return of 20% and a low debt-to-equity ratio 8.1% reflect financial stability and resilience across economic cycles.
Key Catalysts
- Broad product portfolio spanning pharmaceuticals, medical devices, and consumer health
- Strong free cash flow supporting dividends and buybacks
- Conservative balance sheet with minimal leverage
Risk Factors
- Slower revenue growth compared to biotech peers
- Ongoing litigation and regulatory risks
- Margin pressures in consumer health division
Stock #5: Advanced Micro Devices, Inc. (AMD)
| Metric | Value |
|---|---|
| Market Cap | $415.7B |
| Quality Rating | 7.5 |
| Intrinsic Value | $89.4 |
| 1Y Return | 77.8% |
| Revenue | $29.6B |
| Free Cash Flow | $4,043.0M |
| Revenue Growth | 27.2% |
| FCF margin | 13.7% |
| Gross margin | 46.6% |
| ROIC | 4.7% |
| Total Debt to Equity | 6.5% |
Investment Thesis
AMD is a leading semiconductor innovator with a $415.7B market cap and a ValueSense quality rating of 7.5. The company’s $29.6B in revenue and $4B in free cash flow are driven by a 27.2% revenue growth rate and a 13.7% FCF margin. AMD’s 1-year return of 77.8% and a gross margin of 46.6% reflect its competitive edge in CPUs and GPUs for data centers and gaming.
Key Catalysts
- Expansion in AI and high-performance computing markets
- Product launches targeting cloud and enterprise customers
- Strong revenue growth and market share gains
Risk Factors
- Low ROIC 4.7% compared to industry leaders
- High competition from Nvidia and Intel
- Sensitivity to cyclical demand in consumer electronics
Stock #6: Cisco Systems, Inc. (CSCO)
| Metric | Value |
|---|---|
| Market Cap | $289.5B |
| Quality Rating | 6.6 |
| Intrinsic Value | $78.2 |
| 1Y Return | 34.4% |
| Revenue | $56.7B |
| Free Cash Flow | $13.3B |
| Revenue Growth | 5.3% |
| FCF margin | 23.5% |
| Gross margin | 65.1% |
| ROIC | 13.3% |
| Total Debt to Equity | 63.3% |
Investment Thesis
Cisco Systems, with a $289.5B market cap and a ValueSense quality rating of 6.6, is a global leader in networking and cybersecurity. The company’s $56.7B in revenue and $13.3B in free cash flow are supported by a 5.3% revenue growth rate and a 65.1% gross margin. Cisco’s 1-year return of 34.4% and a 23.5% FCF margin highlight its cash generation and operational efficiency.
Key Catalysts
- Growth in cloud networking and security solutions
- Recurring revenue from software and services
- Strong free cash flow supporting capital returns
Risk Factors
- Moderate debt-to-equity ratio 63.3%
- Slower growth in legacy hardware segments
- Competitive pressures from emerging network vendors
Stock #7: International Business Machines Corporation (IBM)
| Metric | Value |
|---|---|
| Market Cap | $287.1B |
| Quality Rating | 6.6 |
| Intrinsic Value | $197.5 |
| 1Y Return | 50.9% |
| Revenue | $65.4B |
| Free Cash Flow | $13.0B |
| Revenue Growth | 4.5% |
| FCF margin | 19.9% |
| Gross margin | 58.2% |
| ROIC | 9.6% |
| Total Debt to Equity | 237.8% |
Investment Thesis
IBM, with a $287.1B market cap and a ValueSense quality rating of 6.6, is a technology and consulting giant. The company’s $65.4B in revenue and $13B in free cash flow are driven by a 4.5% revenue growth rate and a 19.9% FCF margin. IBM’s 1-year return of 50.9% and a gross margin of 58.2% reflect its transition to hybrid cloud and AI-driven services.
Key Catalysts
- Strategic focus on AI, cloud, and consulting
- Recurring revenue from software and services
- Attractive dividend yield for income-focused investors
Risk Factors
- High debt-to-equity ratio 237.8%
- Slow organic growth in legacy businesses
- Execution risk in transformation initiatives
Stock #8: Micron Technology, Inc. (MU)
| Metric | Value |
|---|---|
| Market Cap | $249.7B |
| Quality Rating | 8.4 |
| Intrinsic Value | $368.6 |
| 1Y Return | 124.8% |
| Revenue | $37.4B |
| Free Cash Flow | $8,929.0M |
| Revenue Growth | 48.9% |
| FCF margin | 23.9% |
| Gross margin | 39.8% |
| ROIC | 15.9% |
| Total Debt to Equity | 27.2% |
Investment Thesis
Micron Technology, with a $249.7B market cap and a ValueSense quality rating of 8.4, is a memory and storage leader. The company’s $37.4B in revenue and $8.9B in free cash flow are supported by a 48.9% revenue growth rate and a 23.9% FCF margin. Micron’s 1-year return of 124.8% and a 15.9% ROIC highlight its strong competitive positioning in DRAM and NAND markets.
Key Catalysts
- Surging demand for memory in AI and data center applications
- Technological leadership in next-gen memory products
- High revenue and FCF growth rates
Risk Factors
- Cyclical pricing in memory markets
- Moderate gross margin 39.8% compared to peers
- Capital intensity of manufacturing operations
Stock #9: Salesforce, Inc. (CRM)
| Metric | Value |
|---|---|
| Market Cap | $249.0B |
| Quality Rating | 6.9 |
| Intrinsic Value | $270.9 |
| 1Y Return | -10.5% |
| Revenue | $39.5B |
| Free Cash Flow | $12.5B |
| Revenue Growth | 8.3% |
| FCF margin | 31.6% |
| Gross margin | 77.6% |
| ROIC | 10.8% |
| Total Debt to Equity | 4.6% |
Investment Thesis
Salesforce, with a $249B market cap and a ValueSense quality rating of 6.9, is a global CRM and cloud software leader. The company’s $39.5B in revenue and $12.5B in free cash flow are driven by an 8.3% revenue growth rate and a 31.6% FCF margin. Despite a -10.5% 1-year return, Salesforce’s intrinsic value of $270.9 and a gross margin of 77.6% highlight its profitability and recurring revenue base.
Key Catalysts
- Expansion in AI-driven CRM and analytics
- High-margin subscription revenue model
- Strong free cash flow generation
Risk Factors
- Negative 1-year return signals recent market headwinds
- Low debt-to-equity ratio 4.6% but competitive SaaS landscape
- Integration risks from acquisitions
Stock #10: Philip Morris International Inc. (PM)
| Metric | Value |
|---|---|
| Market Cap | $224.7B |
| Quality Rating | 6.9 |
| Intrinsic Value | $146.9 |
| 1Y Return | 10.0% |
| Revenue | $39.9B |
| Free Cash Flow | $10.1B |
| Revenue Growth | 7.5% |
| FCF margin | 25.3% |
| Gross margin | 66.3% |
| ROIC | 25.0% |
| Total Debt to Equity | (557.5%) |
Investment Thesis
Philip Morris International, with a $224.7B market cap and a ValueSense quality rating of 6.9, is a global tobacco and nicotine products leader. The company’s $39.9B in revenue and $10.1B in free cash flow are supported by a 7.5% revenue growth rate and a 25.3% FCF margin. Philip Morris’s 1-year return of 10% and a 66.3% gross margin reflect its strong cash generation and global reach.
Key Catalysts
- Growth in reduced-risk and smoke-free products
- Strong free cash flow supporting dividends
- High ROIC 25.0% and global brand recognition
Risk Factors
- Negative total debt-to-equity ratio 557.5% signals high leverage
- Regulatory risks and declining cigarette volumes
- ESG headwinds impacting investor sentiment
Portfolio Diversification Insights
This watchlist spans semiconductors, software, healthcare, and consumer staples, offering a blend of growth and defensive characteristics. Technology stocks (AVGO, TSM, AMD, MU, IBM, CSCO, CRM) provide exposure to AI, cloud, and digital transformation, while healthcare (LLY, JNJ) adds stability and innovation. Philip Morris (PM) introduces a non-cyclical, cash-generative component, balancing sector risk and enhancing overall portfolio resilience.
Market Timing & Entry Strategies
ValueSense’s intrinsic value tools help identify entry points by comparing current prices to fair value estimates[1][4]. Investors may consider staggered entries or dollar-cost averaging to mitigate timing risk, especially in volatile sectors like semiconductors. Monitoring earnings reports, macroeconomic indicators, and sector rotation trends can further refine entry strategies.
Explore More Investment Opportunities
For investors seeking undervalued companies with high fundamental quality, our analytics team provides curated stock lists:
📌 50 Undervalued Stocks (Best overall value plays for 2025)
📌 50 Undervalued Dividend Stocks (For income-focused investors)
📌 50 Undervalued Growth Stocks (High-growth potential with strong fundamentals)
🔍 Check out these stocks on the Value Sense platform for free!
More Articles You Might Like
- How VKTX (Viking Therapeutics) Makes Money in 2025: A Deep-Dive With Income Statement
- How NET (Cloudflare) Makes Money in 2025: A Deep-Dive With Income Statement
- How MASS (908 Devices) Makes Money in 2025: A Deep-Dive With Income Statement
- How CRVO (CervoMed) Makes Money in 2025: A Deep-Dive With Income Statement
- How GILD (Gilead Sciences) Makes Money in 2025: A Deep-Dive With Income Statement
FAQ Section
Q1: How were these stocks selected?
Stocks were chosen using ValueSense’s proprietary screening tools, focusing on intrinsic value, quality ratings, growth metrics, and sector diversification[1][2].
Q2: What's the best stock from this list?
Each stock offers unique strengths; however, those with the highest quality ratings and robust growth (e.g., Micron Technology, TSMC, Broadcom) may stand out for further analysis.
Q3: Should I buy all these stocks or diversify?
Diversification across sectors and business models can help manage risk. This watchlist is designed to provide a balanced mix of growth and defensive stocks for educational purposes.
Q4: What are the biggest risks with these picks?
Key risks include sector cyclicality (semiconductors), regulatory changes (healthcare, tobacco), high leverage, and market volatility. Each stock’s risk profile is detailed in its analysis section.
Q5: When is the best time to invest in these stocks?
Optimal timing depends on intrinsic value gaps, earnings cycles, and broader market conditions. ValueSense’s tools can help identify undervalued entry points and support disciplined, long-term strategies.